AETOS Shoulder System
A legfontosabb adatok
- Ki végzi
- Smith & Nephew, Inc.
- Hol
- Bend, Columbus, Denver, Philadelphia és San Francisco (Egyesült Államok)Mind a 5 helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 220 fő, tervezett
- Kezdés
- 2024. márc. 5.
- Várható befejezés
- 2030. aug. 30.
- A vizsgálat típusa
- Megfigyeléses, 2 csoport
- A vizsgált kezelések
- AETOS
- A regiszteradat frissítve
- 2024. május 7.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults having a first planned anatomic or reverse shoulder replacement with the AETOS Shoulder System.
- Életkor
- 18 years or older, with fully grown bones.
- Nem
- All sexes can join.
- A betegség stádiuma
- Shoulder replacement for rheumatoid arthritis, arthritis after an injury, non-inflammatory wear-and-tear joint disease, or to correct a joint deformity.
- Korábbi kezelés
- This must be a first shoulder replacement. People having a redo (revision) shoulder replacement cannot join.
A részvétel fő kizáró okai
- Planned partial (hemi) shoulder replacement, a recent injury or a fracture.
- Uncontrolled diabetes with a hemoglobin A1C of 7.5 or greater.
- Weak or poor bone, severe osteoporosis or osteomalacia, or an active infection.
- BMI over 35kg/m2, pregnancy or plans to become pregnant.
- Smoking, vaping, alcohol or drug abuse within 180 days of consent.
A regiszter feltételei, szó szerint
Mind a 31 feltétel megnézéseKevesebb
Ki vehet részt
- Patients must meet all the following criteria to be included in the study:
- Patient is at least 18 years of age at the time of consent and skeletally mature
- Patient is undergoing a primary elective anatomic or reverse shoulder replacement surgery for one of the following indications:; Rheumatoid arthritis, and/or; Traumatic arthritis (Post Traumatic arthritis), and/or; Non-inflammatory degenerative joint disease, and/or; Correction of functional deformity
- Patient is willing and able to accommodate all study-related procedures and visits detailed in the protocol \& cooperate in the standard of care post-operative therapy
- Patient is geographically stable and willing to return to the study site for all follow-up visits
- Patient has been adequately informed of risks and requirements of the study and is willing and able to provide informed consent for participation; -
Ki nem vehet részt
- Patient is undergoing a revision shoulder replacement surgery including total or partial arthroplasty
- Patient has poor quality or insufficient bone stock to support the implant
- Patient has poor bone quality where there could be considerable migration of the implant and/or a chance of fracture
- Patient has muscular, neurologic, or vascular deficiencies that may compromise the outcome of the shoulder replacement surgery
- Patient has a Body Mass Index (BMI) of >35kg/m2 or a BMI that may compromise the outcome of the shoulder replacement surgery
- Patient has anticipated activities which would impose high stresses on the implant and its fixation or has a high likelihood of a fall
- Patient is a known smoker, vaper, alcohol abuser, or drug abuser within 180 days of consent
- Patient has participated previously in this clinical trial and was withdrawn
- Patient is participating in another device or drug trial or observational competitive study
- Patient has comorbidities/conditions that preclude proper healing/fixation of the implant
- Patient has a known sensitivity, allergic reaction, and/or known allergies to one or more of the implanted materials
- Patient has a distant foci of infection which may spread to the implant site, active local or systemic infection, sepsis, or osteomyelitis
- Patient is uncooperative, has a neurologic disorder and is not capable of following directions, or is a vulnerable subject per ISO 14155 (i.e., individuals who are unable to fully understand all aspects of the investigation that are relevant to the decision to participate, or who could be manipulated or unduly influenced as a result of a compromised position, expectation of benefits or fear of retaliatory response)
- Patient has uncontrolled diabetes with a hemoglobin A1C of 7.5 or greater
- Patient has an elevation of sedimentation rate, elevation of WBC count, or marked shift in WBC differential count unexplained by other disease
- Patients who meet any of the following criteria will not qualify for participation in the trial:
- Patient has a contraindication to AETOS
- Patient is indicated for a Hemiarthroplasty
- Patient has traumatic injury or a fracture
- Patient has rapid joint destruction, marked bone loss or bone resorption (e.g., severe osteoporosis)
- Patient has osteomalacia
- If reverse shoulder arthroplasty, patient has a non-functional deltoid or external rotator muscles
- If reverse shoulder arthroplasty, patient has a significant injury to the upper brachial plexus
- If reverse shoulder arthroplasty, patient has paralysis of the axillary nerve
- Patient is pregnant or plans to become pregnant during the follow-up period
Helyszínek itt: Egyesült Államok
- Center for Orthopedics and Neurosurgical CareBend, Egyesült ÁllamokContact: Cody ManriquezRésztvevőt keres
- Hughston FoundationColumbus, Egyesült ÁllamokContact: Cholly MintonRésztvevőt keres
- Western OrthopaedicsDenver, Egyesült ÁllamokContact: Libby MauterRésztvevőt keres
- Rothman InstitutePhiladelphia, Egyesült ÁllamokContact: Brooke OlinRésztvevőt keres
- California Pacific OrthopedicsSan Francisco, Egyesült ÁllamokContact: Katie SheehiRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
The goal of this study is to confirm the safety and performance of the AETOS Shoulder System for USA adoption. This is a prospective, open, adaptive, non-comparative, multi-centre investigation enrolling a maximum of 220 subjects in 2 cohorts (anatomic and reverse) at up to 15 sites. No intra-study comparator group will be included, and there will be no randomization
A vizsgálat 2 csoportja
- Primary Anatomic
Those subjects who have the AETOS implanted in the Primary Anatomic configuration
Kezelés: AETOS
- Primary reverse
Those subjects who have AETOS implanted in the Reverse configuration
Kezelés: AETOS
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- AETOS Shoulder System Post Market Clinical Investigation
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2024. május 7.